MARYLAND · NAICS NAICS 6211, 6212
Maryland medical and dental acquisitions routinely cross the $250,000 goodwill threshold that triggers an independent going-concern appraisal. The Capital suburbs and the Johns Hopkins and University of Maryland medical systems anchor one of the densest practice markets in the country, where acquisition values clear the appraisal threshold as a matter of course.
FEASIBILITY TRIGGER
Acquisitions routinely cross the $250,000 goodwill threshold triggering an independent going-concern appraisal; startups and relocations are projection-based.
Maryland generated 387 SBA-disbursed medical and dental practice loans between FY2010 and FY2026, worth $166.2 million in approved 7(a) and 504 financing at an average of $429,000 per deal. Ranked #21 of 38 states for medical and dental practice SBA volume, the state captures 1.0% of national medical and dental practice dollars. 93.3% of the loans ran through 7(a) with 504 covering the remainder; 68 approvals have posted since FY2024.
| Disbursed loans (FY2010–FY2026) | 387 |
| Approved volume | $166.2 million |
| Average loan size | $429,000 |
| 7(a) share | 93.3% |
| Approvals since FY2024 | 68 |
| State rank by loan count | #21 of 38 |
Among the 287 seasoned loans in this segment (approvals FY2010–FY2021), 6.6% reached adverse resolution — purchased, liquidated, or charged off. The national benchmark for medical and dental practice is 3.7%, against 7.3% across all industries. That performance runs above the national benchmark for this asset class, which is a factor lenders weigh in their credit decision.
Source: SBA 7(a) and 504 FOIA loan-level data, as of March 31, 2026. Disbursed loans only. See data methodology.
A 6.6% adverse-resolution rate against the national medical and dental practice benchmark of 3.7% tells credit committees to scrutinize revenue projections and coverage assumptions closely on Maryland deals in this class. A rigorous third-party feasibility study — built on documented demand, defensible pricing, and stressed coverage — carries meaningful weight in that underwriting conversation, particularly at an average loan size of $429,000 across 387 loans.
Every Maryland medical and dental practices project we underwrite follows the same lender ready process: independent market analysis, site and technical review, and financial projections tested against SBA SOP 50 10 8 standards. Our SBA feasibility study consultants guide explains scope, timing, deliverables, and what lenders and CDCs expect in the report.
Maryland projects often pencil under SBA 504 because the 50/40/10 structure delivers up to 90 percent financing on owner-occupied real estate at a fixed debenture rate, and SBA 7(a) covers acquisitions, working capital, and equipment. From July 4, 2026 eligible borrowers can combine 7(a) and 504 for up to $10 million in total program credit.
The Capital suburbs and the Johns Hopkins and University of Maryland medical systems anchor one of the densest practice markets in the country, where acquisition values clear the appraisal threshold as a matter of course.
For a national view of this asset class, see our medical and dental practice SBA feasibility overview, and read our related analysis in the medical and dental practice lending research on our blog.
Compare neighboring markets: Maine, Massachusetts, Texas.
Public SBA and CDC program records, cited as program evidence
SBA 504 through PeopleFund
Medical office real estate purchase, national program evidence
Arlington, Tarrant County, Texas
Fifteen-minute scoping call, written proposal inside one business day, firm fixed fee before you sign.
Book a MeetingOur SBA feasibility study consultants prepare multifamily, mixed-use and residential development studies for lenders, CDCs and sponsors. See pricing, methodology or request a fixed fee quote.